Full video transcriptClick to expand
Auto-generated transcript of @andrewverykios's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00250 milligrams of test is not TRT.
- 0:03TRT is actually half that dose if not less
- 0:06when prescribed under a doctor.
- 0:08If you don't want to admit the fact
- 0:10that you're actually cruising on something
- 0:12and you're actually pointing out to the masses
- 0:14that you're saying TRT, that's very incorrect
- 0:16and you're actually misinforming people.
- 0:18And if you want to be on a cruise, that's fine.
- 0:20That is totally fine.
- 0:22Not stopping you.
- 0:23Just stop saying that it's TRT.
- 0:25There's a lot of people alone right now
- 0:26that are saying like,
- 0:28oh, I'm on 300 milligrams of TRT.
- 0:30I'm on 400 milligrams of TRT.
- 0:31Now you're not, you're on a cycle.
- 0:33Like once you've gone beyond 250 milligrams,
- 0:36you're on a cycle, sorry, depending on your body weight
- 0:40and your height, you're on a cycle.
- 0:42So shut the fuck up.
- 0:43Stop insulting people that are actually on TRT.
- 0:46Stop.
TRT misinformation claims on TikTok: what the data says
Quick answer
Standard clinical TRT protocols for hypogonadism target serum testosterone levels within the physiologic range, typically achieved with 75 to 100mg of testosterone cypionate or enanthate per week per Endocrine Society guidelines (Bhasin et al., 2018). Doses of 250mg per week or higher generally produce supraphysiologic peak levels in most men, placing them outside what is conventionally considered replacement therapy. The creator's frustration with misuse of the term "TRT" reflects a real semantic problem in fitness communities, though individual pharmacokinetics mean rigid dose cutoffs are not absolute clinical rules.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT misinformation claims on TikTok: what the data says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT misinformation claims on TikTok: what the data says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "TRT misinformation claims on TikTok: what the data says" from Andrew Verykios. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Standard clinical TRT protocols for hypogonadism target serum testosterone levels within the physiologic range, typically achieved with 75 to 100mg of testosterone cypionate or enanthate per week per Endocrine Society guidelines (Bhasin et al.
The reason this review is not generic is the source wording and the canonical claim label "trt clearing trt misinformation fyp pedcoach peds pedtalk bodybu." In this clip, the useful excerpt is: "250 milligrams of test is not TRT." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Standard clinical TRT protocols for hypogonadism target serum testosterone levels within the physiologic range, typically achieved with 75 to 100mg of testosterone cypionate or enanthate per week per Endocrine Society guidelines (Bhasin et al.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Standard clinical TRT protocols for hypogonadism target serum testosterone levels within the physiologic range, typically achieved with 75 to 100mg of testosterone cypionate or enanthate per week per Endocrine Society guidelines (Bhasin et al., 2018). Doses of 250mg per week or higher generally produce supraphysiologic peak levels in most men, placing them outside what is conventionally considered replacement therapy. The creator's frustration with misuse of the term "TRT" reflects a real semantic problem in fitness communities, though individual pharmacokinetics mean rigid dose cutoffs are not absolute clinical rules.
- Endocrine Society guidelines (Bhasin et al., 2018, JCEM) support TRT dosing of 75 to 100mg of testosterone cypionate or enanthate per week for most men with hypogonadism.
- Bhasin et al. (2001, NEJM) showed that 300mg per week of testosterone enanthate produces supraphysiologic serum levels, supporting the creator's claim that doses above 250mg exceed typical replacement territory.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Endocrine Society guidelines (Bhasin et al., 2018, JCEM) support TRT dosing of 75 to 100mg of testosterone cypionate or enanthate per week for most men with hypogonadism.
- Bhasin et al. (2001, NEJM) showed that 300mg per week of testosterone enanthate produces supraphysiologic serum levels, supporting the creator's claim that doses above 250mg exceed typical replacement territory.
- The number that clinically matters in TRT is not the weekly milligram dose but the serum testosterone trough level, which should stay within the physiologic range of roughly 300 to 1,000 ng/dL.
- Supraphysiologic testosterone use carries cardiovascular risks, including adverse cardiac remodeling, that are distinct from those seen at replacement doses (Baggish et al., 2017, Circulation).
- The creator's hard cutoff of 250mg as the line between TRT and a cycle is a useful rough guide but is not a fixed clinical threshold, since injection frequency and individual pharmacokinetics affect real serum levels.
- Using "TRT" to describe 300 to 400mg per week protocols in fitness content does distort public understanding of what medically supervised hormone therapy looks like and the risk profile it carries.
- Body weight and height are not the primary determinants of whether a dose is supraphysiologic; serum levels measured by blood testing are the actual clinical standard.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @andrewverykios actually say?
The creator's core argument is that 250mg of testosterone per week is not TRT, and that anyone calling it TRT is "misinforming people." He sets a rough ceiling of 250mg as the point where a protocol crosses from replacement into a "cruise" or cycle, while acknowledging body weight and height play a role. His frustration is directed at people he believes are misrepresenting supraphysiologic use as medical therapy. He also suggests true prescribed TRT is "half that dose if not less."
The framing is blunt and opinionated, which isn't necessarily wrong. But some of his specific thresholds deserve scrutiny before they spread as gospel on a platform where 8,500 people just watched them get delivered as settled fact.
Does the science back this up?
Partially, yes. Standard TRT dosing in clinical guidelines is well below 250mg per week, so the creator's general point holds. But the hard cutoff framing is where things get slippery.
The Endocrine Society's clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) recommend testosterone therapy dosed to bring serum testosterone into the normal physiologic range, roughly 300 to 1,000 ng/dL. For testosterone cypionate or enanthate, that typically means 75 to 100mg every week, or 150 to 200mg every two weeks. Some patients with faster metabolism or higher clearance rates may require doses approaching 200mg per week to stay in range, but this is the upper edge of replacement, not the norm.
The idea that 250mg per week is a "cycle" or cruise dose is well-supported by pharmacokinetic data. Bhasin et al. (2001, New England Journal of Medicine) showed that 300mg of testosterone enanthate per week produced supraphysiologic serum levels in healthy men. Two-fifty per week sits in territory where most men will exceed the physiologic ceiling, especially mid-injection-cycle. The creator's directional point is correct.
What did they get wrong (or right)?
He got the core directional claim right: 250mg per week is, for most men, above what's needed for testosterone replacement. Calling it "TRT" does muddy public understanding of what hormone therapy actually looks like in a clinical context.
Where he oversimplifies is the hard threshold. Saying "once you've gone beyond 250 milligrams, you're on a cycle" ignores legitimate clinical variability. A 120kg man with confirmed hypogonadism and rapid testosterone clearance might legitimately require a higher weekly dose to stay within physiologic range on trough testing. The threshold is not a fixed biological law. It depends on injection frequency, ester used, individual pharmacokinetics, and what blood levels the dose actually produces.
He also uses "cruise" and "cycle" somewhat loosely. In bodybuilding culture, a cruise is a low-dose maintenance phase between blasts, often around 150 to 250mg per week. A cycle typically implies a higher-dose, time-limited phase. His definitions aren't wrong exactly, they're just borrowed from gym culture, not clinical medicine.
What should you actually know?
If you're prescribed testosterone, the number that matters is not your weekly dose in milligrams. It's your serum testosterone levels, specifically your trough levels before your next injection. A well-managed TRT protocol targets total testosterone in the mid-to-upper normal range, around 500 to 900 ng/dL for most men, without pushing into supraphysiologic territory.
The creator is right that the term "TRT" gets co-opted in fitness spaces to make performance-enhancing use sound more medically sanctioned. That is a real problem. Research on testosterone's effects at supraphysiologic doses, including cardiovascular strain and hematocrit elevation, comes from studies examining doses of 300mg per week and above (Baggish et al., 2017, Circulation). Conflating that risk profile with medically supervised replacement therapy does a disservice to patients who actually need hormone treatment.
The bottom line: if someone is describing a 300 or 400mg per week protocol as TRT, the creator's skepticism is warranted. The terminology matters because the risk profile at those doses is genuinely different.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Andrew Verykios · TikTok creator
8.5K views on this video
Clearing TRT misinformation #fyp #pedcoach #peds #pedtalk #bodybuildingchippy
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about endocrine society guidelines (bhasin et al., 2018, jcem) support trt?
Endocrine Society guidelines (Bhasin et al., 2018, JCEM) support TRT dosing of 75 to 100mg of testosterone cypionate or enanthate per week for most men with hypogonadism.
What does the video say about bhasin et al. (2001, nejm) showed?
Bhasin et al. (2001, NEJM) showed that 300mg per week of testosterone enanthate produces supraphysiologic serum levels, supporting the creator's claim that doses above 250mg exceed typical replacement territory.
What does the video say about the number?
The number that clinically matters in TRT is not the weekly milligram dose but the serum testosterone trough level, which should stay within the physiologic range of roughly 300 to 1,000 ng/dL.
What does the video say about supraphysiologic testosterone use carries cardiovascular risks, including adverse cardiac remodeling,?
Supraphysiologic testosterone use carries cardiovascular risks, including adverse cardiac remodeling, that are distinct from those seen at replacement doses (Baggish et al., 2017, Circulation).
What does the video say about the creator's hard cutoff of 250mg as the line between?
The creator's hard cutoff of 250mg as the line between TRT and a cycle is a useful rough guide but is not a fixed clinical threshold, since injection frequency and individual pharmacokinetics affect real serum levels.
What does the video say about using "trt" to describe 300 to 400mg per week protocols?
Using "TRT" to describe 300 to 400mg per week protocols in fitness content does distort public understanding of what medically supervised hormone therapy looks like and the risk profile it carries.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Andrew Verykios, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.